CN102481377B - 糖基化相关的材料和方法 - Google Patents
糖基化相关的材料和方法 Download PDFInfo
- Publication number
- CN102481377B CN102481377B CN201080031987.3A CN201080031987A CN102481377B CN 102481377 B CN102481377 B CN 102481377B CN 201080031987 A CN201080031987 A CN 201080031987A CN 102481377 B CN102481377 B CN 102481377B
- Authority
- CN
- China
- Prior art keywords
- group
- fluorine
- alkyl
- polypeptide
- glycosylation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *C(C(C(*)(CC(*)*C1*)*1(*)NC(O)S)F)C(*)(*)I Chemical compound *C(C(C(*)(CC(*)*C1*)*1(*)NC(O)S)F)C(*)(*)I 0.000 description 1
- OZSQDNCDEHVGBC-UHFFFAOYSA-N CC(C)(C(C)(C)O)N Chemical compound CC(C)(C(C)(C)O)N OZSQDNCDEHVGBC-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (27)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18743409P | 2009-06-16 | 2009-06-16 | |
US61/187,434 | 2009-06-16 | ||
PCT/GB2010/001188 WO2010146362A2 (en) | 2009-06-16 | 2010-06-16 | Materials and methods relating to glycosylation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102481377A CN102481377A (zh) | 2012-05-30 |
CN102481377B true CN102481377B (zh) | 2014-10-29 |
Family
ID=43086298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080031987.3A Active CN102481377B (zh) | 2009-06-16 | 2010-06-16 | 糖基化相关的材料和方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US9452223B2 (zh) |
EP (1) | EP2442831B9 (zh) |
JP (2) | JP6091892B2 (zh) |
CN (1) | CN102481377B (zh) |
CA (1) | CA2768155C (zh) |
ES (1) | ES2560557T3 (zh) |
HK (1) | HK1169336A1 (zh) |
PL (1) | PL2442831T3 (zh) |
WO (1) | WO2010146362A2 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2560557T3 (es) * | 2009-06-16 | 2016-02-19 | Glythera Limited | Materiales y métodos con relación a la glicosilación de polipéptidos terapéuticos |
TW201442721A (zh) * | 2013-01-23 | 2014-11-16 | Daiichi Sankyo Co Ltd | 糖鏈修飾心房利尿鈉肽 |
TWI687428B (zh) * | 2014-03-27 | 2020-03-11 | 中央研究院 | 反應性標記化合物及其用途 |
RU2656140C2 (ru) * | 2016-11-14 | 2018-05-31 | Федеральное государственное бюджетное учреждение "Государственный научный центр Институт иммунологии" Федерального медико-биологического агентства России | Способ получения гибридного белка, состоящего из рекомбинантного белка аналога интерферона гамма, конъюгированного с олигосахаридом |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5770407A (en) * | 1996-12-10 | 1998-06-23 | The Scripps Research Institute | Process for preparing nucleotide inhibitors of glycosyltransferases |
CN1635901A (zh) * | 2001-10-10 | 2005-07-06 | 尼奥斯药制品有限公司 | 肽的重构和糖缀合 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0576592B1 (en) | 1991-03-18 | 2000-05-31 | The Scripps Research Institute | Oligosaccharide enzyme substrates and inhibitors: methods and compositions |
US7226903B2 (en) | 2001-10-10 | 2007-06-05 | Neose Technologies, Inc. | Interferon beta: remodeling and glycoconjugation of interferon beta |
JP4752001B2 (ja) * | 2002-10-16 | 2011-08-17 | ザ スクリプス リサーチ インスティチュート | 糖蛋白質合成 |
PL2144923T3 (pl) | 2007-04-03 | 2013-12-31 | Biogenerix Ag | Sposoby leczenia z użyciem glikopegilowanego G-CSF |
US8173597B2 (en) | 2007-11-09 | 2012-05-08 | Baxter International Inc. | Modified recombinant factor VIII and von Willebrand factor and methods of use |
ES2560557T3 (es) * | 2009-06-16 | 2016-02-19 | Glythera Limited | Materiales y métodos con relación a la glicosilación de polipéptidos terapéuticos |
-
2010
- 2010-06-16 ES ES10727485.4T patent/ES2560557T3/es active Active
- 2010-06-16 CN CN201080031987.3A patent/CN102481377B/zh active Active
- 2010-06-16 CA CA2768155A patent/CA2768155C/en active Active
- 2010-06-16 WO PCT/GB2010/001188 patent/WO2010146362A2/en active Application Filing
- 2010-06-16 PL PL10727485T patent/PL2442831T3/pl unknown
- 2010-06-16 JP JP2012515554A patent/JP6091892B2/ja active Active
- 2010-06-16 EP EP10727485.4A patent/EP2442831B9/en active Active
- 2010-06-16 US US13/378,192 patent/US9452223B2/en active Active
-
2012
- 2012-10-17 HK HK12110238.7A patent/HK1169336A1/zh unknown
-
2015
- 2015-06-16 JP JP2015121185A patent/JP2015187153A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5770407A (en) * | 1996-12-10 | 1998-06-23 | The Scripps Research Institute | Process for preparing nucleotide inhibitors of glycosyltransferases |
CN1635901A (zh) * | 2001-10-10 | 2005-07-06 | 尼奥斯药制品有限公司 | 肽的重构和糖缀合 |
Also Published As
Publication number | Publication date |
---|---|
CN102481377A (zh) | 2012-05-30 |
WO2010146362A2 (en) | 2010-12-23 |
EP2442831B9 (en) | 2016-05-11 |
EP2442831A2 (en) | 2012-04-25 |
US20120190631A1 (en) | 2012-07-26 |
JP6091892B2 (ja) | 2017-03-08 |
JP2012530119A (ja) | 2012-11-29 |
JP2015187153A (ja) | 2015-10-29 |
ES2560557T3 (es) | 2016-02-19 |
CA2768155A1 (en) | 2010-12-23 |
HK1169336A1 (zh) | 2013-02-22 |
CA2768155C (en) | 2016-08-23 |
EP2442831B1 (en) | 2015-11-04 |
PL2442831T3 (pl) | 2016-06-30 |
US9452223B2 (en) | 2016-09-27 |
WO2010146362A3 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2935611B1 (en) | Glycoengineered antibody, antibody-conjugate and methods for their preparation | |
US20160250347A1 (en) | Modified glycoprotein, protein-conjugate and process for the preparation thereof | |
EP3057618B1 (en) | Glycoengineered antibody, antibody-conjugate and methods for their preparation | |
US20190225706A1 (en) | Modified glycoprotein, protein-conjugate and process for the preparation thereof | |
AU2005208897B2 (en) | Branched polymeric sugars and nucleotides thereof | |
CN102481377B (zh) | 糖基化相关的材料和方法 | |
CN102317305B (zh) | 硫醇基官能化试剂及其用途 | |
US20090292110A1 (en) | Enzymatic modification of glycopeptides | |
WO2009024977A2 (en) | Saccharide-containing protein conjugates and uses thereof | |
US20240238432A1 (en) | Method for glycoprotein modification | |
JP4871739B2 (ja) | 分枝高分子糖およびそのヌクレオチド | |
MXPA06008447A (es) | Azucares polimericos ramificados y nucleotidos de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JILI SILA CO., LTD. Free format text: FORMER OWNER: UNIVERSITY OF BATH (GB) CLAVERTON DOWN, BATH BA2 7AY, ENGLAND Effective date: 20141105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20141105 Address after: The Tyne and wear in Newcastle upon Tyne Patentee after: GLYTHERA LIMITED Address before: Bath, United Kingdom Patentee before: THE University OF BATH |
|
CP03 | Change of name, title or address |
Address after: The Tyne and wear in Newcastle upon Tyne Patentee after: Icosta Medical Co., Ltd. Address before: Newcastle, Tyne River, Tyne-Willshire Patentee before: GLYTHERA LIMITED |
|
CP03 | Change of name, title or address |